Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BW A868C, a hydantoin compound and structural analogue of BW245C, functions as a selective and potent competitive antagonist of prostaglandin D2 (PGD2), showing no activity on other prostaglandin receptors (IP, EP1, EP2, TP, and FP) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 218.00 | |
5 mg | 35 days | $ 960.00 | |
10 mg | 35 days | $ 1,700.00 |
Description | BW A868C, a hydantoin compound and structural analogue of BW245C, functions as a selective and potent competitive antagonist of prostaglandin D2 (PGD2), showing no activity on other prostaglandin receptors (IP, EP1, EP2, TP, and FP) [1]. |
In vitro | BW A868C antagonizes PGD2- and BW245C-induced activation of human platelet adenylate cyclase [1]. |
Molecular Weight | 459.58 |
Formula | C25H37N3O5 |
CAS No. | 118675-50-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BW A868C 118675-50-6 inhibitor inhibit